NO972219L - Immunogenpreparater - Google Patents

Immunogenpreparater

Info

Publication number
NO972219L
NO972219L NO972219A NO972219A NO972219L NO 972219 L NO972219 L NO 972219L NO 972219 A NO972219 A NO 972219A NO 972219 A NO972219 A NO 972219A NO 972219 L NO972219 L NO 972219L
Authority
NO
Norway
Prior art keywords
immunogen
antigens
solvent
preparation according
preparation
Prior art date
Application number
NO972219A
Other languages
English (en)
Norwegian (no)
Other versions
NO972219D0 (no
Inventor
Roger Randal Charles New
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of NO972219D0 publication Critical patent/NO972219D0/no
Publication of NO972219L publication Critical patent/NO972219L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO972219A 1994-11-15 1997-05-14 Immunogenpreparater NO972219L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422990A GB9422990D0 (en) 1994-11-15 1994-11-15 Immunogenic compositions
PCT/GB1995/002675 WO1996014871A1 (en) 1994-11-15 1995-11-14 Immunogenic compositions

Publications (2)

Publication Number Publication Date
NO972219D0 NO972219D0 (no) 1997-05-14
NO972219L true NO972219L (no) 1997-07-11

Family

ID=10764393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972219A NO972219L (no) 1994-11-15 1997-05-14 Immunogenpreparater

Country Status (19)

Country Link
EP (1) EP0792165B1 (de)
JP (1) JP4297515B2 (de)
KR (1) KR970706848A (de)
CN (1) CN100346828C (de)
AT (1) ATE249841T1 (de)
AU (1) AU700910B2 (de)
CA (1) CA2205083A1 (de)
DE (1) DE69531793T2 (de)
DK (1) DK0792165T3 (de)
ES (1) ES2210318T3 (de)
FI (1) FI972054A0 (de)
GB (1) GB9422990D0 (de)
IL (1) IL116010A0 (de)
MX (1) MX9703480A (de)
NO (1) NO972219L (de)
NZ (1) NZ295238A (de)
PT (1) PT792165E (de)
WO (1) WO1996014871A1 (de)
ZA (1) ZA959729B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323588D0 (en) 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation
US6165773A (en) * 1995-10-25 2000-12-26 Provalis Uk Limited Methods of preserving viruses
GB9613858D0 (en) 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
AU736038C (en) * 1997-07-10 2006-08-10 Intervet Australia Pty Limited Non-aqueous vaccines
AR013202A1 (es) * 1997-07-10 2000-12-13 Biotech Australia Pty Ltd Vacunas no acuosas
JP2002502884A (ja) * 1998-02-12 2002-01-29 アメリカン・サイアナミド・カンパニー インターロイキン−12および単純ヘルペスウイルス抗原を含んでなるワクチン
IL137810A0 (en) * 1998-02-12 2001-10-31 American Cyanamid Co Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
CN1200730C (zh) * 1998-02-12 2005-05-11 惠氏控股有限公司 用白细胞介素-12配制的肺炎球菌和脑膜炎球菌疫苗
CA2330610A1 (en) * 1998-05-07 1999-11-11 Corixa Corporation Adjuvant composition and methods for its use
CA2337445A1 (en) 1998-07-16 2000-01-27 Sumitomo Pharmaceuticals Co., Ltd. Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
ES2588705T3 (es) 2007-09-27 2016-11-04 Immunovaccine Technologies Inc. Uso de liposomas en un vehículo que comprende una fase hidrófoba continua para la entrega de polinucleótidos in vivo
AU2008307042B2 (en) * 2007-10-03 2014-01-30 Immunovaccine Technologies Inc. Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
CA2723918C (en) 2008-06-05 2018-01-09 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
EP2654782A4 (de) * 2010-12-23 2015-03-25 Immport Therapeutics Inc Verfahren und zusammensetzungen aus proteinantigenen zur diagnose und behandlung von toxoplasma-gondii-infektionen und toxoplasmose
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
CN102277373B (zh) * 2011-08-15 2014-07-02 南京大学 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用
IN2014CN02581A (de) 2011-10-06 2015-08-07 Immunovaccine Technologies Inc

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
ATE233547T1 (de) * 1991-06-26 2003-03-15 Yamanouchi Europ Bv Vesiculae in nichtpolaren medien
AU7384994A (en) * 1993-08-06 1995-02-28 Opperbas Holding B.V. A method for high loading of vesicles with biopolymeric substances
GB9323588D0 (en) * 1993-11-16 1994-01-05 Cortecs Ltd Hydrophobic preparation

Also Published As

Publication number Publication date
KR970706848A (ko) 1997-12-01
FI972054L (fi) 1997-05-14
WO1996014871A1 (en) 1996-05-23
DE69531793D1 (de) 2003-10-23
IL116010A0 (en) 1996-01-31
PT792165E (pt) 2004-02-27
AU3853495A (en) 1996-06-06
ES2210318T3 (es) 2004-07-01
NZ295238A (en) 1999-01-28
EP0792165B1 (de) 2003-09-17
CN100346828C (zh) 2007-11-07
MX9703480A (es) 1997-08-30
JP4297515B2 (ja) 2009-07-15
JPH10508834A (ja) 1998-09-02
FI972054A7 (fi) 1997-05-14
EP0792165A1 (de) 1997-09-03
CA2205083A1 (en) 1996-05-23
CN1163575A (zh) 1997-10-29
FI972054A0 (fi) 1997-05-14
NO972219D0 (no) 1997-05-14
DK0792165T3 (da) 2004-01-05
ATE249841T1 (de) 2003-10-15
AU700910B2 (en) 1999-01-14
ZA959729B (en) 1997-05-15
GB9422990D0 (en) 1995-01-04
DE69531793T2 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
AU700910B2 (en) Immunogenic compositions
US5716637A (en) Solid fat nanoemulsions as vaccine delivery vehicles
US6803042B2 (en) Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides
Alving Design and selection of vaccine adjuvants: animal models and human trials
WO1995011700A1 (en) Submicron emulsions as vaccine adjuvants
MXPA97003480A (en) Immunogeni compositions
US9603799B2 (en) Liposomal vaccine adjuvants and methods of making and using same
EP2195022A1 (de) Zusammensetzungen mit einem antigen, einer amphipathischen verbindung und einem hydrophoben träger und ihre verwendungen
HU220136B (hu) Eljárás liposzómákat tartalmazó vakcinakészítmény előállítására
US20130195932A1 (en) Archaeal polar lipid aggregates for administration to animals
Gregoriadis Liposomes as immunological adjuvants for peptide and protein antigens
AU744308B2 (en) Antigen vectors in the form of multilamellar vesicles
US20100209452A1 (en) Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
US20160136250A1 (en) Hydrophobic Preparations
WO2001019335A2 (fr) Compositions destinees a une administration par voie muqueuse
Muderhwa et al. Emulsification of liposomes with incomplete Freund's adjuvant: Stability of the liposomes and the emulsion
FR2850872A1 (fr) Composition vaccinale destinee a induire une reponse immunitaire contre le virus responsable du sida
Wilkhu et al. Designing nonionic surfactant vesicles for the delivery of antigens for systemic and alternative delivery routes
RU97110170A (ru) Иммуногенные композиции

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application